CenterPoint Energy Inc. logo

CenterPoint Energy Inc. (0HVF)

Market Closed
6 Jun, 15:30
$
36. 63
-0.45
-1.21%
$
- Market Cap
22.9 P/E Ratio
0.84% Div Yield
3,787 Volume
1.5 Eps
$ 37.08
Previous Close
Day Range
36.37 37
Year Range
25.41 39.22
Earnings results expected in 47 days

Summary

0HVF closed Friday lower at $36.63, a decrease of 1.21% from Thursday's close, completing a monthly decrease of -5.03% or $1.94. Over the past 12 months, 0HVF stock gained 14.08%.
0HVF pays dividends to its shareholders, with the most recent payment made on Mar 13, 2025. The next announced payment will be in In 1 day on Jun 12, 2025 for a total of $0.22.
The last earnings report, released on Apr 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.23%, based on the last three reports. The next scheduled earnings report is due on Jul 28, 2025.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track 0HVF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

0HVF Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial

- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks - For the TransCon CNP-treated cohort, combination treatment resulted in mean AGV of 8.25 cm/year, with an improvement in mean ACH height Z-score of +0.44 over 26 weeks - The combination of TransCon hGH and TransCon CNP demonstrated accelerated improvement in body proportionality at Week 26, aligning with the increase in linear growth - Safety and tolerability data consistent with those observed for TransCon hGH and TransCon CNP monotherapies; combination treatment was generally well tolerated, with generally mild treatment-emergent adverse events (TEAEs) - Ascendis to host conference call today at 8:00 am ET COPENHAGEN, Denmark, June 09, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 26 interim analysis results from its ongoing COACH Trial, the first clinical trial to evaluate combination treatment with once-weekly investigational TransCon CNP (navepegritide) and once-weekly TransCon hGH (lonapegsomatropin) in children with achondroplasia. Results demonstrated that TransCon hGH boosted treatment benefits of TransCon CNP, resulting in significant growth and proportionality improvements in children with achondroplasia after 26 weeks of combination treatment, with a safety and tolerability profile consistent with those observed for TransCon hGH and TransCon CNP monotherapies.

Globenewswire | 1 day ago
2025 Atlantic Hurricane Season: CenterPoint Energy emphasizes preparedness with critical resiliency efforts completed before June 1; urges customers to have an emergency plan and practice that plan

2025 Atlantic Hurricane Season: CenterPoint Energy emphasizes preparedness with critical resiliency efforts completed before June 1; urges customers to have an emergency plan and practice that plan

Historic series of Greater Houston Resiliency Initiative key improvements completed ahead of schedule to strengthen the grid and reduce the impact of outages from major storms Joint emergency response exercise completed; community safety and preparedness events continue with emergency officials and local partners CenterPoint continues proactive outreach and communication efforts across Greater Houston service area to help customers prepare for upcoming storm season HOUSTON , June 3, 2025 /PRNewswire/ -- With the 2025 Atlantic hurricane season officially underway, CenterPoint Energy is reinforcing the resiliency and preparedness efforts the company already completed to strengthen grid resiliency, improve local emergency coordination and help communities and customers better prepare for potential severe weather. Last month, CenterPoint held its 2025 emergency response exercise as part of a coordinated effort with public officials, emergency response managers and community partners to improve local cooperation and response efforts.

Prnewswire | 1 week ago
FDA Accepts TransCon® CNP NDA for Priority Review

FDA Accepts TransCon® CNP NDA for Priority Review

– Once-weekly TransCon CNP demonstrated significantly higher annualized growth velocity, the primary endpoint, compared to placebo

Globenewswire | 1 week ago

CenterPoint Energy Inc. (0HVF) FAQ

What is the stock price today?

The current price is $36.63.

On which exchange is it traded?

CenterPoint Energy Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is 0HVF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 28, 2025.

Has CenterPoint Energy Inc. ever had a stock split?

CenterPoint Energy Inc. had 0 splits and the recent split was on Oct 01, 2002.

CenterPoint Energy Inc. Profile

General Utilities Industry
Utilities Sector
Mr. Jason P. Wells CPA CEO
LSE Exchange
US15189T1079 ISIN
US Country
8,872 Employees
15 May 2025 Last Dividend
1 Oct 2002 Last Split
2 Jan 1970 IPO Date

Overview

CenterPoint Energy, Inc. is a notable public utility holding company based in the United States, with its origins tracing back to 1866. The company's headquarters are situated in Houston, Texas, reflecting its strong presence in several states, including Indiana, Louisiana, Minnesota, Mississippi, Ohio, and Texas. It operates through two primary segments: Electric and Natural Gas. CenterPoint Energy plays a critical role in providing transmission, distribution, and generation services for electricity, while also delivering natural gas to a wide array of customers, ranging from residential to industrial and institutional sectors. The company’s infrastructure and operations are substantial, with a notable number of metered customers and extensive facilities that underline its capacity and commitment to energy distribution and services.

Products and Services

  • Electric Transmission and Distribution
  • This segment focuses on the delivery of electricity to customers, alongside managing electric generation assets. CenterPoint Energy also partakes in optimizing these assets within the wholesale power market, ensuring reliable electricity supply and distribution across its service territories.

  • Natural Gas Sales and Distribution
  • CenterPoint Energy is engaged in the sales and distribution of natural gas to diverse customer sectors including residential, commercial, industrial, and institutional clients. The company's operations in this segment highlight its role in ensuring the consistent provision of natural gas, facilitated through a comprehensive network of pipelines and service connections.

  • Pipeline Connections and Repair Services
  • Through its Natural Gas segment, CenterPoint Energy maintains permanent pipeline connections by interfacing with various interstate and intrastate pipeline companies. Additionally, it offers maintenance and repair services for home appliances, predominantly in Minnesota. This service extends to providing home repair protection plans through third parties in select states, adding an essential layer of customer support and service reliability.

Contact Information

Address: 1111 Louisiana Street
Phone: 713 207 1111